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Background: Sonoelastography is a novel and promising imaging tool, which has been applied to breast, thyroid,
and prostate tissues. The aim of this study was to evaluate focal lesions of the testes with diameters of <10 mm
using sonoelastography, B-mode sonography (US), and colour Doppler ultrasonography (CDU).
Methods: Thirty patients who were referred to our outpatient clinics for varicocoeles, scrotal pain, scrotal enlargements,
epididymitis, palpable testicular nodules, or infertility, were prospectively enrolled into this study. Ultrasound evaluations
had revealed that 27 subjects had focal testicular lesions with diameters of <10 mm and 3 subjects had 10-mm spherical
non-homogeneous testicular nodules. All lesions were evaluated using semiquantitative sonoelastography, and the
patients underwent orchifunicolectomies. The testicular lesions were examined histopathologically. The vascularization of
the lesions and the surrounding testicular parenchyma was evaluated by analysing the immunohistochemical distribution
of the cluster of differentiation 31 and by calculating the vascular indices (VI). Potential associations between the strain
ratios (stiffness of the lesions) and the VI were tested.
Results: Analyses of the strain fields obtained using semiquantitative sonoelastography yielded different values for the
masses and the surrounding tissues, which led to significant increases in the strain ratios. Sonoelastography upheld all of
the diagnoses that were suspected when the patients were physically examined, when the serum markers were analysed,
and after the patients had undergone US and CDU. Histopathological examinations confirmed the neoplastic
characteristics of these masses. A significant inverse correlation was determined between the sonoelastographic strain
ratio and the VI (Pearson correlation coefficient, r, = − 0.93; P < 0.001).
Conclusion: Our investigation shows that semiquantitative sonoelastography may provide additional objective
information to support the algorithm used to diagnose testicular lesions. This might be of crucial diagnostic
importance for lesions with diameters of <10 mm, particularly if they are not palpable, are negative for serum tumour
markers, and if the findings from ultrasonography and CDU are equivocal. The findings from semiquantitative
sonoelastography might indicate the need for surgical exploration. Further investigations with larger numbers of
patients are required to corroborate these data and to support the use of semiquantitative sonoelastography in the
evaluation of testicular lesions.
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Ultrasonographic elastography, or sonoelastography, is a
novel diagnostic modality that is under investigation for
its clinical application to cancer diagnostics [1-4], and
primarily for lesional imaging of the breast [3,5-9], thy-
roid [10,11], and prostate [12-14]. However, sonoelasto-
graphy is not routinely used in the clinical environment.
An important characteristic of a tissue is its inherent
elasticity, which may be altered by the pathophysio-
logical processes associated with ageing, inflammation,
and the presence of tumours. In this context, elasticity is
defined as the tension (i.e. stress) needed to produce a
relative change in length (i.e. strain), and it describes the
amount of pressure that must be exerted on a tissue to
achieve elastic deformation. In principle, elasticity can
be derived from the stress and strain parameters mea-
sured in tissue structures. While strain can be computed
from high-frequency echo signals, stress cannot be dir-
ectly determined from tissue measurements. During
ultrasonographic examinations of tissues, compressibil-
ity is a standard parameter that is considered in the dif-
ferential diagnoses of lesions. A non-compressible mass
detected during B-mode sonography (US) is associated
with an increased likelihood of malignancy. Sonoelasto-
graphy is based on strain imaging, and preliminary data
on a possible role for sonoelastography in the evaluation
of testicular lesions have been reported [15-17]. This
study compared US, which is a widely used diagnostic
sonographic method, with semiquantitative sonoelasto-
graphy, which is a new method for visualizing the elastic
characteristics of tissues, in the evaluation of testicular
nodules with diameters of <10 mm. To explore the out-
comes generated by this tool in greater depth, we tested
the relationship between the strain ratio data obtained
using sonoelastography, and the vascular indices (VI)
that were determined from the immunohistochemical
analysis of the testicular lesions.
Methods
Patients
Between March 2010 and January 2013, 30 male patients
with an average age of 37 years (range 22–50 years), pre-
sented with the following findings: 9 patients had scrotal
enlargements, 6 of whom had unilateral epididymitis and
3 of whom had idiopathic scrotal pain; 7 patients had
palpable hard testicular nodules, 4 of whom were referred
to our clinic because of varicocoeles; and 14 patients vis-
ited our outpatient clinic because of infertility issues and
they did not present with any palpable lesions.
All patients were investigated using US and colour
Doppler ultrasonography (CDU), which enabled the
presence of testicular lesions to be confirmed, their lar-
gest diameters to be calculated, and their vascular con-
figurations to be explored.These lesions were then evaluated using semiquantita-
tive sonoelastography (ElastoQ). The patients underwent
orchifunicolectomies within 1 week of their diagnostic
algorithms being fulfilled, which included the evaluation
of tumour markers in the serum. Histopathology was
performed on all of the lesions.
The study was performed according to the principles of
the Declaration of Helsinki 2000. Local ethics committee
approval was obtained (ASL Lt/no.12985678), and written
informed consent was acquired from all patients.
Semiquantitative sonoelastography
Semiquantitative sonoelastography was performed while
the patient rested in a supine position on a bed, using
the Aplio XG Colour Doppler System (Toshiba Medical
Systems Corporation, Tokyo, Japan) equipped with a 5–
14-MHz linear transducer. The probe was placed on the
testis while applying light pressure. At this time, the op-
erator can see a curve representing the entity and the
mode of compression in the lower portions of the dis-
play. This allows the operator to analyse the shape of the
compression/decompression curve and verify that the
amount of compression is optimal. Semiquantitative
sonoelastography software calculates the strain ratio,
with the terminal phase of decompression being selected
for the calculation, because it is less dependent on the
force exerted and is therefore more consistent.
During sonoelastography, the operator highlighted the
nodule being evaluated, and this was referred to as the
region of interest (ROI). The ROI was manually drawn
to correspond with the nodule and it was at an elevation
plane that corresponded with the extralesional paren-
chyma. The size of the ROI was defined by the operator
as the area of abnormal tissue selected. Another area of
the same size as the ROI was then selected within the
normal tissue to enable the areas to be compared and to
determine the strain ratio. Two ultrasonic images were
acquired during sonoelastography: one was acquired be-
fore tissue compression by the probe and the other was
obtained after tissue compression. Tissue displacement
was tracked by assessing the propagation of the imaging
beam, and tissue distortion was accurately measured using
the dedicated software. Once the raw data had been ac-
quired, a chromatic map was superimposed onto the US
image using a colour scale that ranges from red, indicating
components with the greatest elastic strain (i.e. the softest
components), to blue that indicates components with no
elastic strain (i.e. the hardest components).
In this study, the sonoelastographic images were
matched with an elasticity colour scale and classified using
the elasticity score developed by Ueno and Itoh [1]. The
strain values for the oldest periods of compression or de-
compression were calculated automatically from the vel-
ocity profiles of all of the frames. The image of the frame
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imum was displayed. The same operator performed all of
the examinations.
To calculate the strain, we chose the optimal decom-
pression value for each lesion. This enabled the strain
ratio of the ROI to be obtained by comparing the elastic
characteristics of the lesion with the elastic characteris-
tics of the normal tissue. The echogenicity ratio was de-
termined by comparing the echogenicity of the lesion
with that of the normal tissue using the greyscale func-
tion. It is possible to define ElastoQ as a modification of
the real-time method, because it allows off-line analysis
of the deformation values (i.e. strain) of a mass while
utilizing the raw data generated by changes in radiofre-
quencies before and after tissue compression. The calcu-
lation is performed by selecting an ROI within the lesion
under investigation and a reference region in an area of
normal parenchymal elasticity. The result is an index of
deformation (i.e. strain index) that is relative to the ref-
erence value of the tissue. The strain index increases as
the rigidity of the structure being examined increases.
This method can also be used to determine a lesion’s de-
gree of echogenicity by comparing it with nearby normal
structures, while considering the absolute values of
echogenicity expressed in the raw data.
Histopathological examination of the lesions
All of the patients underwent orchifunicolectomy. The sur-
gical specimens from the primary tumours were submitted
for histological examination in 10% neutral-buffered forma-
lin, and were then processed and embedded in paraffin
wax. Sections were cut at 5 μm and stained with haema-
toxylin and eosin. Two pathologists reviewed the sections
and categorized the tumours using the World Health Orga-
nization’s histological classification of testicular cancer.
Immunohistochemistry was performed using the Bond
Polymer Refine Detection system (Leica Biosystems,
Newcastle, UK) and the cluster of differentiation (CD)
31 antibody (PECAM-1; Clone 1A10, Leica Biosystems,
Newcastle, UK), at a dilution of 1:100, to determine the
distribution of CD31, and hence the vascularization of
the primary tumours and the surrounding testicular tis-
sues. Two pathologists evaluated these sections at a 10×
magnification (Figure 1). The results were expressed as
percentages and the VI was calculated, which was de-
rived from the difference between the vascularization of
the lesion and the vascularization of the surrounding
testicular parenchyma.
Statistical analysis
The strain ratios and VI results were statistically ana-
lysed by calculating the linear regression between the
two variables. The Pearson correlation coefficient, r, was
used to test for a linear association between the strainratio and the VI. An α error below 5% was considered
statistically significant. The statistical analyses were per-
formed using IBM® SPSS® version 18.0 (IBM, Armonk,
New York, USA).
Results
When examined by US, 27/30 patients had subcentimetre
hypoechoic lesions and 3 patients had 1-cm non-
homogeneous spherical lesions. Only 7/30 lesions showed
clear evidence of increased vascular flows when examined
by CDU. The findings in these 7 patients combined with
the positive lesional palpations detected during the phys-
ical examinations, which raised suspicions about the pres-
ence of neoplastic disease, prompted us to assess all of
the patients for the presence of the following tumour
markers: alpha-fetoprotein, carcinoembryonic antigen, hu-
man chorionic gonadotropin, and lactate dehydrogenase.
Only 4/30 patients were positive for these tumour markers.
Semiquantitative sonoelastography provided data that
supplemented those generated by US and CDU. Specific-
ally, this tool demonstrated that the normal testicular tis-
sue and nodules had different elastographic patterns, with
the latter showing stiffer sonoelastographic signals, par-
ticularly at the perimeters of the masses (Figures 2, 3, 4),
which was suggestive of pathological tissue, and has been
described in previous reports [5]. These findings corrobo-
rated our suspicions about the neoplastic origins of these
lesions; consequently, we performed orchifunicolectomies.
The histopathological examinations determined the pres-
ence of 18 seminomas, of which 15 were classic, 2 were
anaplastic, and 1 was spermatocytic, 3 mixed-germ cell tu-
mours, containing embryonal carcinomas, yolk sac tu-
mours, and seminomas, 2 embryonal carcinomas, and 7
Leydig cell tumours. The 2 patients with embryonal carcin-
omas and 2/3 individuals with mixed tumours were positive
for the serum tumour markers. The vascularization of the
primary tumours and the surrounding testicular paren-
chyma was evaluated immunohistochemically using the
CD31 antibody, and this was used to calculate the VI. The
Pearson correlation coefficient showed a significant in-
verse correlation between the sonoelastographic strain
ratio (stiffness of the lesion) and the VI (r = − 0.93; P <
0.001) (Figure 5). The clinical features of the patients, to-
gether with their histopathological results, strain ratios,
and VI are summarized in Table 1.
Discussion
Testicular masses can be difficult to diagnose, particu-
larly when they have a diameter of <1 cm and/or are not
palpable. Palpation provides subjective data, but physi-
cians need instrumental support to make informed deci-
sions about therapy when the lesion is small. Evaluations
using US combined with CDU are commonly used to
characterize testicular lesions, but these evaluations do
Figure 1 Immunohistochemical analysis of vascularization using the CD31 antibody. (A) Seminoma, (B) embryonal carcinoma, and
(C) Leydig cell tumour (10× magnification).
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of the masses. This information might help to corroborate
diagnostic assessments, especially when masses with small
diameters are found incidentally. Sonoelastography can be
used to evaluate the mechanical elastic properties of soft
tissues, which are determined by their macromolecules and
structural organization. This is the first report describing
the use of semiquantitative sonoelastography to investigate
subcentimetre testicular masses, which could be promising
potential targets for this new imaging technology. Indeed,
the information obtained through sonoelastography in this
study has contributed to the diagnostic evaluation of tes-
ticular lesions, because it has given an insight into their
atypical compositions and it has emphasized the need for a
high level of clinical suspicion about malignancy in the con-
text of subcentimetre testicular tumours. Our data concur
with those from previously reported studies [15-17] and
they ratify the potential role of sonoelastography in the
evaluation of testicular nodules.
Sonoelastography evaluates the radiofrequencies that
arise from structures before and after they are subjected to
manual or mechanical compression. Manual compressionFigure 2 Cystic nodule with high SR (6.15) in peripheral solid portionand mechanical compression are the different sonoelasto-
graphic techniques used to cause deformation of the struc-
tures under investigation. The intensity of the change in
the radiofrequency of the ultrasound pulse rises as the se-
verity of the deformation and the elasticity of the tissue
increase. The evaluation of the strain or deformation in-
duced by manual compression is a clinically proven method
for the evaluation of tumours [1-4,11-13].
This technique does not require any additional hardware,
and it only requires the software associated with the sonoe-
lastographic system [11]. The data obtained using this sys-
tem are shown on the monitor in real time with a colour
map superimposed onto the ultrasonographic image that
arbitrarily encodes the structure’s elasticity characteristics.
The data are expressed in terms of the tissue deformation
capacity of the structure in question.
Sonoelastographic results can be affected by several fac-
tors including coarse calcifications, cysts, and out-of-plane
displacements, which can compress the lesion under
examination. However, the testis is mobile and it is not ad-
jacent to any bony structures. Since real-time sonoelasto-
graphy is based on the superimposition of polychromatics (6 mm) in a 22 years old patient.
Figure 3 Solid nodule (7 mm) with high SR (2.69) discovered during ultrasound scan in a 36 years old patient with primary infertility.
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determined subjectively and nodular lesions are scored
from E1 to E5 in accordance with the mapping scheme
defined by Ueno and Itoh [1]. Previous studies of real-
time sonoelastography have demonstrated that scores of
E4 and E5 have high predictive values for malignancy, the
ability of the score to predict malignancy is independent
of nodule size, and that high specificities and sensitivities
are maintained for lesions of <1 cm diameter [18].
In our study, we sought to substantially reduce the sub-
jectivity associated with evaluating the colour maps in real
time by replacing the classification system with a numer-
ical parameter, that is, the strain ratio, which is not oper-
ator dependent, is reproducible, and enables the elasticity
of lesions to be given unique classifications. To ensure the
objectivity of the assessment, we also attempted to define
a cut-off value that would differentiate between likely be-
nign nodular lesions and likely malignant lesions, and to
add a numerical parameter that would help guide the next
clinical step, for example, clinical monitoring with or with-
out treatment, or surgical excision. This was possible withFigure 4 Solid nodule (5 × 4 mm) with modest intralesional vascularithe semiquantitative sonoelastography system, because it
expresses the deformation capacity of the structure under
investigation relative to the normal (reference) tissue as an
absolute value or as a strain ratio. Therefore, semiquanti-
tative sonoelastography represents a modification of the
real-time method and enables the off-line analysis of a
nodule’s strain values by analysing variations in radio-
frequencies using the raw data. The calculation is per-
formed by selecting an ROI within the nodular formation
and a reference region in an area of normal parenchymal
elasticity. The result is an index of deformation (i.e. a
strain index or a coefficient of elasticity) that can be com-
pared with the organ’s reference values, and that rises as
the rigidity of the structure being examined increases.
Using this method, the coefficient of echogenicity can also
be determined by comparing the echogenicity of the lesion
with that of nearby normal structures, while taking into
account the absolute values of echogenicity expressed in
the raw data.
In a preliminary study, Grasso et al. [19] used sonoe-
lastography to evaluate various pathological conditionsty and extremely high SR (23.2) in 42 years old patient.
Figure 5 The significant inverse correlation between the strain ratio (stiffness of the lesion) and the vascular index (VI) relating to
neoangiogenesis within the tumour. This could be interpreted as the ability to quantify angiogenesis using sonoelastography.
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with scrotal pain, painless enlargements of the scro-
tum, testicular nodules, and infertility. The authors
concluded that sonoelastography could provide add-
itional valuable information, because compared with
other sonographic methods, it provided better clarity
in patients who had solid testicular lesions with diam-
eters of <10 mm. Grasso et al. [19] highlighted
the advantages of the technique when using it to dif-
ferentiate between neoplastic masses that exhibit
homogeneous hardening and haematomas that are
characterized by non-homogeneous sonoelastographic
patterns. Other authors support the use of sonoelas-
tography for the evaluation of testicular masses. For
example, Magarelli et al. [15] reported that sonoelas-
tography helps to elucidate those ambiguous soft-
tissue lesions that are identified using conventional
ultrasonographic techniques. Furthermore, Aigner
et al. [16] evaluated 50 individuals affected by testicu-
lar masses using sonoelastography. They found that
34/50 of the lesions were tumours, and they reported
that sonoelastography can provide additional informa-
tion about patients who have indeterminate ultra-
sonographic findings, because of its higher specificity
compared with other sonographic methods. A recent
publication by Goddi et al. [17] reported the results
of 88 consecutive testicular evaluations using sonoe-
lastography. In their experience, real-time tissue elas-
tography gave 87.5% sensitivity, 98.2% specificity, a93.3% positive predictive value, a 96.4% negative pre-
dictive value, and 95.8% accuracy in differentiating
between malignant and benign lesions. Most of the
malignant lesions within this case series (87.5%)
showed a stiff elastographic pattern, leading the au-
thors to conclude that real-time tissue elastography
differentiates between benign and malignant testicular
lesions more effectively [17].
Our experience demonstrates that semiquantitative
sonoelastography is a viable option for the evaluation
of testicular nodules, and that it might offer an instru-
mental option that could support conventional ultra-
sonographic approaches in the diagnostic algorithm for
testicular nodules, especially in the diagnosis of am-
biguous and non-palpable lesions. The findings from
this study suggest that tumours emit signals indicative
of stiffer tissues, especially in the region around a tu-
mour’s perimeter. Given that this was found in all of
the tumours examined, signals indicative of stiffer tis-
sues within suspicious echographic areas of the testis
might be considered reliable indicators of pathological
tissues. In the current study population, only 4 pa-
tients were positive for tumour markers in their sera,
27 individuals had subcentimetre lesions, and only 7
individuals had palpable masses. Hence, not all of the
subjects had definitive diagnoses of neoplastic disease.
The data generated by semiquantitative sonoelastogra-
phy provide further evidence that the lesions discovered
during the physical examinations, US, and CDU were
Table 1 Clinical features of the patients, their histopathological results, strain ratios, and vascular indices











1 41 Scrotal pain Positive (βhCG) 5.7 Embryonal carcinoma Chemotherapy 56 10%
2 50 Epididymitis, cryptorchidism Negative 8.6 Classic seminoma NO 34,5 20%
3 32 Infertility Positive (βhCG, AFP) 7.9 Embryonal carcinoma Chemotherapy 16,8 40%
4 35 Infertility, palpable testicular node Negative 10.4 Classic seminoma NO 8,57 48%
5 34 Epididymitis Negative 5.6 Classic seminoma NO 6,43 42%
6 35 Infertility, palpable testicular node Negative 10.3 Classic seminoma NO 3,8 48%
7 35 Infertility Negative 5.9 Classic seminoma NO 12,3 35%
8 37 Infertility Negative 5.8 Leydig cell tumor NO 12,5 32%
9 38 Infertility Positive (AFP) 6.5 Mixed germ cell tumor Chemotherapy 12,5 41%
10 22 Varicocele, palpable testicular node Negative 6.1 Classic seminoma NO 6,15 44%
11 28 Varicocele Negative 7.6 Mixed germ cell tumor Chemotherapy 3,8 47%
12 41 Infertility Negative 7.8 Leydig cell tumor NO 3,44 46%
13 49 Palpable testicular nodule Negative 9.6 Leydig cell tumor NO 4,2 48%
14 36 Infertility Negative 6.9 Anaplastic seminoma Radiotherapy 2,69 48%
15 42 Infertility Negative 5.1 Leydig cell tumor NO 23,2 35%
16 38 Infertility, cryptorchidism Negative 7.9 Spermatocytic seminoma NO 58 10%
17 33 Epididymitis Negative 8.6 Classic seminoma NO 33.5 20%
18 24 Varicocele, palpable testicular node Negative 10.2 Classic seminoma NO 14.8 37%
19 29 Varicocele Negative 7.4 Classic seminoma NO 9.47 49%
20 37 Infertility, cryptorchidism Positive (AFP) 6.5 Mixed germ cell tumor Chemotherapy
and RLND
6.51 43%
21 43 Epididymitis Negative 4.3 Leydig cell tumor NO 4.7 48%
22 42 Infertility Negative 4.6 Classic seminoma NO 12.6 36%
23 46 Scrotal Pain Negative 5.4 Leydig cell tumor NO 11.5 31%
24 22 Varicocele, palpable testicular node Negative 8.8 Classic seminoma NO 12.9 41%
25 36 Infertility Negative 6.3 Classic seminoma NO 8.2 44%
26 36 Epididymitis, cryptorchidism Negative 5.6 Anaplastic seminoma NO 8.8 50%
27 33 Infertility Negative 6.7 Classic seminoma NO 5.34 45%
28 39 Scrotal pain Negative 4.3 Classic seminoma NO 5.34 48%
29 22 Varicocele, palpable testicular node Negative 8.7 Classic seminoma NO 3.79 45%
30 36 Epididymitis Negative 5.6 Leydig cell tumor NO 21 30%
Abbreviations: AFP alpha fetoprotein, LDH lactate dehydrogenase, βhCG beta human chorionic gonadotropin, RLND retroperitoneal lymph node dissection.
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thermore, the immunohistochemical analysis undertaken
in our study demonstrated a linear inverse correlation
between the strain ratio values and the VI. It could be
postulated that this inverse correlation is an expression
of the lesions’ diminished consistencies and greater
intralesional vascularity. This finding could be further
interpreted as hypervascular tumours having lower levels of
consistency than hypovascular tumours. Hence, sonoelasto-
graphy could quantify the magnitude of intralesional micro-
circulation or neoangiogenesis, and substantiate the
consistency of testicular masses. Together, these addimportant elements to diagnostic and prognostic assess-
ments. Given that the main limitation of the present study
was the small number of patients, further investigations
with larger numbers of patients are required to corroborate
these data and to support the use of semiquantitative
sonoelastography in the evaluation of testicular lesions.
Conclusion
Among the patients studied, we found that semiquantita-
tive sonoelastography provided valuable additional object-
ive information about solid testicular lesions, which was of
crucial diagnostic importance, and that it confirmed the
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mours were <10 mm in diameter. The results from this
patient series indicate that semiquantitative sonoelastogra-
phy is a promising adjunctive modality for evaluating the
consistency and microvascularity of testicular lesions.
However, future studies using larger numbers of patients
are necessary to validate these data.
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